NOAA hosting virtual dive to Lake Ontario shipwreck
May 20—As the Lake Ontario Marine Sanctuary plan advances, NOAA invites the public to dive into some of the marine heritage of the lake.
The National Oceanic and Atmospheric Administration has scheduled a virtual diving expedition in which the agency and partners will deploy a remotely operated vehicle outfitted with a high-definition camera and other technologies to survey and document a sanctuary shipwreck as the public looks on.
The virtual dive is 10 a.m. to noon on Friday. Chief scientists Ben Ioset and expedition leader Jason Fahy will host. It can be viewed on the NOAA Sanctuaries YouTube channel. The date and time are subject to change, depending on weather conditions.
A U.S. National Marine Sanctuary, managed by NOAA, is a zone where the marine environment enjoys special protection.
The Lake Ontario National Marine Sanctuary, designated last year, acts as an educational and cultural gateway between the Great Lakes and the Atlantic Ocean and protects culturally significant places, resources and artifacts integral to American history and the heritage of indigenous peoples.
The sanctuary features a collection of 63 known shipwrecks and one known submerged aircraft, among the best preserved in the world, discovered over decades by local recreational scuba divers and shipwreck explorers. It ends just past Tibbetts Point Lighthouse in Cape Vincent, where Lake Ontario flows into the St. Lawrence River.
"The new wreck we plan to dive during the live stream was located in 2022 by the NOAA survey vessel Thomas Jefferson, which was then conducting hydrographic survey for nautical charting of Lake Ontario," said Ioset, Maritime archaeologist at the National Marine Sanctuary Foundation in support of NOAA's Office of National Marine Sanctuaries."The wreck is in more than 550 feet of water and no one has used a remotely operated vehicle to dive it yet, so we do not know what the shipwreck is."
Ioset said that the shipwreck is located mid-lake, near the Canadian border, approximately 15 miles off of Oswego.
At 1:30 p.m. Wednesday, May 28, expedition highlights will be shared, including collected dive footage and stories from the science party of Friday's dive. It will also be broadcast live on the NOAA Sanctuaries YouTube channel.
"This expedition is a remarkable opportunity for our scientists and for the sanctuary, combining state-of-the-art marine imaging and a remotely operated vehicle to document some of the best preserved shipwrecks in the world, right here on Eastern Lake Ontario," Ioset said. "This project will greatly advance the sanctuary's ability to not only protect these historic shipwrecks, but to interpret their significance to the public."
Friday's live-streamed virtual dive is one of a series of dives planned by NOAA.
"We will be exploring a number of different shipwrecks daily for the next two weeks," Ioset said. "We plan to dive on two wrecks per day, weather and equipment permitting. Only the dive on May 23rd will be live broadcast to the public. The footage of the other dives will eventually be publicly available online once we've processed the data."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
2 hours ago
- Hamilton Spectator
Marc Garneau left lasting legacy on Earth and in space, former colleagues say
MONTREAL - Canadian scientists working on asteroid missions, exploring the universe through the James Webb Space Telescope or helping to put rovers on Mars say they can in some way thank Marc Garneau, who left an enduring legacy both as an astronaut and head of the country's space agency. While best-known in later years as a federal cabinet minister, Garneau, who died this week at 76, was also a Navy officer, a systems engineer, and an astronaut with a lifelong passion for science, according to his friends and colleagues. In 1984, he made history as the first Canadian in space when he served as a payload specialist aboard the Space Shuttle Challenger. He returned to space twice more, in 1996 and 2000, before serving as the president of the Canadian Space Agency from 2001 to 2005. 'All his life was devoted to public service,' said Gilles Leclerc, an ex-CSA official who worked with him. 'And he was really a role model to all the Canadian astronauts who came after him.' As CSA president, Garneau laid the building blocks for the space exploration program that would bring together other initiatives previously developed separately, Leclerc said. He was also 'ahead of his time' when it came to being conscious of the environment and understanding the importance of applying space technology for practical uses such as satellite communications. 'During his tenure, he really wanted us to focus more on science: astronomy, planetary science, lunar exploration,' Leclerc said in a phone interview. 'So all these things that now we see, all these missions that Canada participated in, like a mission to the asteroids, two missions to Mars, the James Webb Space had a real strong influence in shaping the future of the space program for a long time.' On Friday, CSA President Lisa Campbell paid tribute to Garneau, who she called a 'cherished member of the space agency family.' 'We remain deeply grateful for his extraordinary public service and enduring contributions to Canada and the world, from making history as the first Canadian in space to guiding the Canadian Space Agency as its president,' she said at an event at the agency's Montreal-area headquarters. 'his integrity, his generosity of spirit touches everyone who had the privilege of working with him.' Flags at government buildings in Montreal have been lowered to half-mast in tribute. Garneau would carry his love of science — as well as his significant technical knowledge — into his next role as a politician, according to his former chief of staff and close personal friend. Marc Roy said Garneau decided to run for office out of a desire to give back after his successful space career. Garneau often spoke about how seeing the Earth from above 'changed his perspective on many things,' including conflicts and environmental protections, Roy said. 'So many things that unfortunately divide us as humans that become so irrelevant when you look at our world from abroad,' Roy said in a phone interview. 'And that desire to want to contribute at an even higher level, at a different, at a policy level, at a governance level is what inspired him to run for federal politics.' Garneau was elected as MP in Notre-Dame-de-Grâce–Westmount in 2008 after failing to win another Montreal-area seat in 2006. Roy said Garneau's scientific background shone through most clearly as Transport minister, when he was able to instantly grasp technical briefings on ships, planes and trains. Above all, his history as a naval officer and astronaut gave him a laser focus on safety, Roy said, in a role that would see Garneau introduce measures including the safer skies initiative, and the oceans protection plan to monitor ship traffic, oil spills and wildlife. Roy said Garneau often spoke about the weight of the portfolio, 'wanting to ensure that he did it to the best of his ability, that he truly understood every decision that he was taking and every decision that was possible for him to make in order to ensure the safety of the traveling public and the safety overall of our trade and transportation corridors.' Roy said Garneau brought a scientist's analytic, 'Spock-like' demeanor to his roles. But he said some of the issues Garneau championed most passionately were social causes, including serving as a joint chair of the special joint committee on medical assistance in dying. And, despite his considerable intelligence, Roy said Garneau remained humble. 'He had a very rare quality in a politician, from his very debut until the very last day before he retired as member of Parliament, which was: he listened more than he talked,' Roy said. He said his friend was diagnosed only months ago with two cancers: leukemia and lymphoma, and died after a battle that was 'brave but short.' Roy said his friend's time since retirement was spent enjoying time with his wife, Pam, and his children, and completing work on his autobiography, 'A Most Extraordinary Ride: Space, Politics and the Pursuit of a Canadian Dream.' Roy said the book gave Garneau closure. 'He wanted to tell the story that, 'I'm just like everybody else and I failed and I've screwed up and I pulled up my socks and I learned from my mistakes and I moved on,'' Roy said. 'And that was very important for him to tell that story, and I'm just so fortunate that he had the time to do that.' This report by The Canadian Press was first published June 7, 2025.
New York Post
2 hours ago
- New York Post
Menopause drug might prevent breast cancer and treat hot flashes, research finds
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.
Axios
7 hours ago
- Axios
The great poaching: America's brain drain begins
The Trump administration's spending cuts and restrictions on foreign students are triggering a brain drain — and American scientists are panicking. Why it matters: U.S. researchers' fears are coming true. America's science pipeline is drying up, and countries like China are seizing the opportunity to surge ahead. 'This is such a race for being the science powerhouse that you never fully recover,' says Marcia McNutt, president of the National Academy of Sciences. 'You might accelerate back up to 60, but you can't make up for those years when you were at a standstill while the competition was racing ahead.' Driving the news: The National Science Foundation, which funds much of America's fundamental science research, is already doling out grants at its slowest pace in 35 years, The New York Times reports. More cuts to science could come with the "big, beautiful bill." Universities are also watching with bated breath as the administration tries to limit the number of foreign students studying in the U.S.. Harvard is pushing back, but could face a total ban on recruiting internationally. The Trump administration says it will " aggressively revoke" visas for Chinese students studying in "critical fields." By the numbers: While American universities are rescinding offers to incoming PhD students, other countries are recruiting heavily from U.S. labs. The journal Nature analyzed data from its jobs platform to track where scientists are looking for work. In the first few months of the Trump administration, there were jumps in the the number of U.S. applicants looking for jobs in Canada (+41%), Europe (+32%), China (+20%) and other Asian countries (+39%), compared to the same period in 2024. U.S. jobs saw fewer applications from candidates in Canada (–13%) and Europe (–41%). Case in point: France's Aix-Marseille University, which made headlines for earmarking millions of dollars for U.S. scientists, closed its application window after receiving a flood of apps. After American Nobel laureate Ardem Patapoutian's federal grant was frozen, he got an email from China offering 20 years of funding if he relocates his lab, The New York Times' Kate Zernike writes. He declined. 'This is a once-in-a-century brain gain opportunity,' the Australian Strategic Policy Institute wrote in a brief. The other side: The White House argues that its changes to the system will usher in a golden age of science and rebuild public trust. President Trump has also suggested that spots freed up by rejecting international students could be filled by American applicants. But professors say this isn't entirely realistic. "In hard sciences, in astronomy and physics and computer science, for example, there's no way you would fill that hole with local applicants of comparable quality," says Chris Impey, an astronomer at the University of Arizona. What to watch: 'The optimistic part of all of us thinks science is strong enough to outlast one administration, and for a while I thought that, but the hit to young people is at the center of the whole enterprise,' Impey says. 'It's like pulling the rug out from under the whole thing." It's not just brain drain of existing talent, he says. Students who are in high school and college now and thinking about a career in research might reconsider. "There's plenty of things smart kids can do. They don't have to go into science." At the same time, McNutt says she tells students: "If you went into graduate school in the fall of this year, by the time you get your PhD, this madness may be over. You come out with your new PhD ready to fill the gap."
